| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 03/17/1994 | CA2143678A1 Compositions and methods for treatment of hepatitis c virus-associated diseases |
| 03/17/1994 | CA2143207A1 4-hydroxy coumarin derivatives with antibacterial activity |
| 03/17/1994 | CA2142708A1 Cationic-2-heteroarylphenyl-carbapenem antibacterial agents |
| 03/17/1994 | CA2142275A1 4-oxo-azetidine-2-sulphonic acid amides and their salts, process for their production and their use |
| 03/17/1994 | CA2140930A1 Anti-viral sulfur-analogues of 1,5-dideoxy-1,5-imino-d-glucitol (deoxynojirimycin) |
| 03/16/1994 | EP0587436A1 Process for preparing carbapenem and penem compounds and new compounds involved in that process |
| 03/16/1994 | EP0587396A1 Use of hypoxoside derivatives for the treatment of viral infections |
| 03/16/1994 | EP0587374A2 Sulfated sterol glycosides and their use against viral infections. |
| 03/16/1994 | EP0587311A1 Peptides capable of inhibiting the activity of HIV protease, their preparation and their therapeutic use |
| 03/16/1994 | EP0587121A1 Crystalline dihydrate of a cephalosporin dihydrochloride salt and injectable compositions thereof |
| 03/16/1994 | EP0586738A1 Enhanced chemotherapeutic compositions against microbial infections in fish containing a benzylamine derivative and an antimicrobial substance |
| 03/16/1994 | EP0586663A1 Carbapenem derivatives as antibiotics and intermediates thereof |
| 03/16/1994 | EP0586632A1 Benzodiazepinones and medicines containing them |
| 03/16/1994 | EP0586618A1 The use of nucleic acid analogues in diagnostics and analytical procedures. |
| 03/16/1994 | EP0586535A1 Methods and compositions based on inhibition of cell invasion and fibrosis by anionic polymers |
| 03/16/1994 | EP0586474A1 Peptide nucleic acids |
| 03/16/1994 | EP0586438A1 Hepatitis a virus production |
| 03/16/1994 | EP0446262B1 Implant for use in bone surgery |
| 03/16/1994 | EP0354246B1 5'-Phosphonates of 3'-azido-2',3'-dideoxynucleosides |
| 03/16/1994 | CN1083814A Heterocyclic compounds |
| 03/16/1994 | CN1083813A Process for preparing guanine-containing antiviral agents and purinyl salts useful in such process |
| 03/16/1994 | CN1083805A 7-(substituted)-9-|(substituted glycyl) amido¨-6-demethyl-6-deoxytetracyclines |
| 03/16/1994 | CN1083728A Taste-masking composition of bitter pharmaceutical agents |
| 03/16/1994 | CN1083704A Method of treatment of HIV-seropositive individuals with dietary whey proteins |
| 03/16/1994 | CN1083703A Pharmaceutical composition with functions of antialcohol, promoting change of energy, of mucosa of stomach, acidification, secretion, antradiation and anticholera |
| 03/16/1994 | CN1024012C New cephalosporin derivatives and antibiotics containing the same |
| 03/16/1994 | CN1024011C Method for producing cephalosporin compounds |
| 03/16/1994 | CA2469296A1 Isoindole intermediates for preparing 7-isoindolinyl-quinolone derivatives and 7-isoindolinyl-naphthyridone derivatives |
| 03/15/1994 | US5294720 1,4-diamino-2,3-dihydroxybutanes |
| 03/15/1994 | US5294645 Using menth-1-en-9-ol to kill bacteria, yeast, and fungi |
| 03/15/1994 | US5294609 DNA gyrase inhibitors and pharmaceutical preparations therefor |
| 03/15/1994 | US5294533 Detection of food poisoning bacteria, bacterial meningitis |
| 03/15/1994 | CA2105646A1 Use of therapeutic agent from mycobacterium vaccae against hiv infections with aids |
| 03/12/1994 | CA2105811A1 Enhanced chemotherapeutic compositions against microbial infections in fish, the preparation and use thereof |
| 03/10/1994 | DE4230053A1 4-Oxo-azetidin-2-sulfonsäureamide und ihre Salze, Verfahren zu deren Herstellung und ihre Verwendung 4-oxo-azetidine-2-sulfonic acid amides and their salts, processes for their preparation and their use |
| 03/10/1994 | CA2105746A1 Process for preparing carbapenem and penem compounds and new compounds involved in that process |
| 03/09/1994 | EP0586298A1 Inhibitor of herpes simplex viral thymidine kinase |
| 03/09/1994 | EP0586266A1 DNA fragments coding for the Neisseria meningitidis receptor fragments |
| 03/09/1994 | EP0586076A2 Recombinant adenovirus vaccines |
| 03/09/1994 | EP0585939A2 TNF ligands |
| 03/09/1994 | EP0585681A2 Use of IL-4 receptors for the therapy, prophylaxis and diagnosis of allergic, viral, paracitic and bacterial diseases, as well as of fungal infections |
| 03/09/1994 | EP0585398A1 Hcv genomic sequences for diagnostics and therapeutics |
| 03/09/1994 | EP0585381A1 THE ASTROVIRUS HUMAN GASTROENTERITIS AGENTS AND MOLECULAR CLONING OF CORRESPONDING cDNAs |
| 03/09/1994 | EP0585267A1 Herpesvirus particles and vaccine |
| 03/09/1994 | EP0585257A1 Dna and amino acid sequence specific for natural killer cells |
| 03/09/1994 | EP0262207B1 Beta-lactam antibiotics |
| 03/09/1994 | CN1083524A Deletion mutants as vaccines for cholera |
| 03/09/1994 | CN1083477A 4-Iminochinolin and preparation and application of same |
| 03/09/1994 | CN1083473A Novel compounds |
| 03/09/1994 | CA2101571A1 Crystalline dihydrate of a cephalosporin dihydrate salt and injectable compositions thereof |
| 03/08/1994 | US5292738 Anti-virally active pyridazinamines |
| 03/08/1994 | US5292733 Cephalosporin compounds |
| 03/08/1994 | US5292650 Aerobic culture |
| 03/08/1994 | US5292648 Microorganism of genus eupenicillium |
| 03/08/1994 | US5292513 Method for nonspecific cellular immune stimulation |
| 03/08/1994 | US5292505 HIV treatment |
| 03/08/1994 | US5291896 Cardiac output probe assembly |
| 03/08/1994 | CA2105630A1 Method of treating viral infections |
| 03/08/1994 | CA1327589C 1-[(2-fluorophenyl)(4-fluorophenyl)phenylmethyl]- 1h-imidazole, its obtention and its use in the preparation of antifungal compositions |
| 03/08/1994 | CA1327580C 7-(3-amino-1-pyrrolidinyl)-1-cyclopropyl-6-fluoro-1, 4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid derivatives |
| 03/08/1994 | CA1327573C Pyridazinamine derivatives |
| 03/03/1994 | WO1994004702A2 Improved detection and therapy of lesions with biotin/avidin conjugates |
| 03/03/1994 | WO1994004690A1 Bispecific immunoadhesins |
| 03/03/1994 | WO1994004688A2 Cationic peptides and method for production |
| 03/03/1994 | WO1994004686A1 Tat-derived transport polypeptides |
| 03/03/1994 | WO1994004683A1 Bordetella bronchiseptica vaccine |
| 03/03/1994 | WO1994004678A1 Immunoglobulins devoid of light chains |
| 03/03/1994 | WO1994004676A1 Stress protein epitopes |
| 03/03/1994 | WO1994004661A1 Virus obtainable from human neuroblastoma cells |
| 03/03/1994 | WO1994004614A1 Metal-mediated cross-coupling with ring-metalated porphyrins |
| 03/03/1994 | WO1994004535A1 Trifluoromethylpyrroloindole carboxylic ester derivative and process for producing the same |
| 03/03/1994 | WO1994004493A1 Sulfonylalkanoylamino hydroxyethylamino sulfonamides useful as retroviral protease inhibitors |
| 03/03/1994 | WO1994004492A1 Hydroxyethylamino sulfonamides useful as retroviral protease inhibitors |
| 03/03/1994 | WO1994004491A1 N-(alkanoylamino-2-hydroxypropyl)-sulfonamides useful as retroviral protease inhibitors |
| 03/03/1994 | WO1994004179A1 Method for inhibiting hiv replication using il-4 |
| 03/03/1994 | WO1994004163A1 Novel glucan preparation |
| 03/03/1994 | WO1994004162A1 Astragalus polysaccharide immunomodulators |
| 03/03/1994 | WO1994004161A1 Use of inhibitors of vacuolar-type h+ atpases |
| 03/03/1994 | WO1994004160A1 Treatment of human viral infections |
| 03/03/1994 | WO1994004154A1 ENANTIOMERICALLY PURE β-D-DIOXOLANE-NUCLEOSIDES |
| 03/03/1994 | WO1994004121A1 Bystander suppression of retroviral-associated neurological disease |
| 03/03/1994 | WO1994004033A1 Anti-microbial composition |
| 03/03/1994 | WO1994004017A2 New method of treatment |
| 03/03/1994 | WO1993015205A3 Synthetic haemophilus influenzae conjugate vaccine |
| 03/03/1994 | DE4228787A1 Neue HIV-1-Virusisolate eines Subtyps, Vakzine gegen HIV-1-Virusinfektionen dieses Subtyps und Verfahren zu ihrer Herstellung, Verwendung der HIV-1-Virusisolate New HIV-1 isolates of subtype vaccine against HIV-1 virus infection of this subtype and methods for their production, use of the HIV-1 virus isolates |
| 03/03/1994 | CA2224048A1 Test kit for testing microbiologically-contaminated material |
| 03/03/1994 | CA2142902A1 Virus obtainable from human neuroblastoma cells |
| 03/03/1994 | CA2142881A1 Detection and therapy of lesions with biotin/avidin conjugates |
| 03/03/1994 | CA2142831A1 Treatment of human viral infections |
| 03/03/1994 | CA2142456A1 Anti-microbial composition |
| 03/03/1994 | CA2142313A1 Use of inhibitors of vacuolar-type h atpases |
| 03/03/1994 | CA2142306A1 Cationic peptides and method for production |
| 03/03/1994 | CA2142270A1 Astragalus polysaccharide immunomodulators |
| 03/03/1994 | CA2140280A1 Bispecific immunoadhesins |
| 03/03/1994 | CA2105345A1 Chemical compound |
| 03/03/1994 | CA2104895A1 Inhibitor of herpes simplex viral thymidine kinase |
| 03/02/1994 | EP0585058A1 Pharmaceutical compositions containing fatty acids and heparin |
| 03/02/1994 | EP0585057A1 Lithium salts of fatty acids for the treatment of viral infections and cancer |
| 03/02/1994 | EP0584797A2 Novel cephalosporin compounds and processes for the preparation thereof |
| 03/02/1994 | EP0584558A2 A composition for suppressing infection and growth of human immunodeficiency virus using an iron-binding protein |